Other

Duramed Pharmaceuticals, Inc.

Jencap Research Ltd.

Duramed Pharmaceutials, Inc.

Militza K Ausmanas

Robert Frederic Casper

Gary A Shangold

A hormone replacement therapy, comprising a plurality of daily doses of a pharmaceutical preparation, the doses being administered continuously and consecutively in alternating phases of three daily doses, a relatively dominant estrogenic activity phase comprising three daily doses of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17&#x3b2;-estradiol per day, and a relatively dominant progestagenic activity phase of a combination of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17&#x3b2;-estradiol and a substance exhibiting progestogenic activity equivalent to about 90 &#x3bc;g per day of norgestimate.

Low dose estrogen interrupted hormone replacement therapy

A hormone replacement therapy, comprising a plurality of daily doses of a pharmaceutical preparation, the doses being administered continuously and consecutively in alternating phases of three daily doses, a relatively dominant estrogenic activity phase comprising three daily doses of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17&bgr;-estradiol per day, and a relatively dominant progestagenic activity phase of a combination of a substance exhibiting estrogenic activity equivalent to about 1 mg per day of 17&bgr;-estradiol and a substance exhibiting progestogenic activity equivalent to about 90 &mgr;g per day of norgestimate.

Growing community of inventors

Lake Forest, IL, United States of America

Militza K Ausmanas